Special clinical concerns/problems in the management of MDS and secondary acute myeloid leukemias.
Venugopal
P
P
Rush Cancer Institute, Rush Presbyterian St. Luke's Medical Center, Chicago, IL, USA.
Manson
S
S
Preisler
H D
HD
D000208:Acute Disease; D000328:Adult; D000367:Age Factors; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D016913:Blood Component Transfusion; D019496:Cancer Vaccines / Q000627:therapeutic use; D019090:Case Management; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D016503:Drug Delivery Systems; D015316:Genetic Therapy; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000235:genetics / Q000628:therapy*; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy / Q000235:genetics / Q000628:therapy*; D016609:Neoplasms, Second Primary / Q000188:drug therapy / Q000235:genetics / Q000628:therapy*; D010166:Palliative Care; D012008:Recurrence; D012074:Remission Induction
D019496:Cancer Vaccines